2011-05-18, 03:54 AM
Mira Wrote:[...] Besides, the sort of progress necessary for real results will happen in a university lab, not a pharmaceutical one.
One more thing - iPS cell grafts will not suffer from rejection. The iPS cells are cells taken from the patient the grafts are used on, so there is no chance of rejection.
The above stated are not true. A great deal of drugs came from research at pharmaceutical labs. But yes it is also true that many of the new developments come from universities and research institutes, but you still need pharma labs to do the majority of the drug research.
And I am way ahead of you. I do happen to have access to the latest news.
http://www.sfgate.com/cgi-bin/article.cg...1JG69R.DTL
http://www.nature.com/news/2011/110513/f...s=news_rss
doi:10.1038/nature10135
You think so now?
The immediate negative of what I said will not be true. Who said that everyone is going to give up? This is what I want: tell me something when a treatment passes the phase II trials - those would have much more hope, and can be used on [a limited number of] patients.
Hadriel